CALYX Bioprocess Technologies, LLC

Multi-Platform Recombinant Protein Expression: Membrane Proteins, Direct mRNA Delivery, and Transient Plant-Based Systems

Technology
In development
Company

Three complementary protein expression platforms for challenging targets: scalable membrane protein production in ultra-high-density photobioreactors, rapid direct mRNA delivery to plant protoplasts, and transient agroinfiltration with self-replicating viral vectors. Supports rapid screening and scale-up across diverse protein classes, with functional recovery demonstrated for membrane proteins and pilot-scale bioreactor validation.

Overview

CALYX Bioprocess Technologies offers a portfolio of complementary recombinant protein expression platforms designed to address difficult-to-express proteins, particularly membrane proteins and targets where conventional transcriptional regulation limits yield. The three routes span rapid small-scale screening through scalable production:

  • Membrane protein expression in ultra-high-density, thin-film anaerobic photobioreactors
  • Direct mRNA delivery to plant protoplasts for rapid, transcription-unconstrained expression
  • Transient expression in plant tissues via agroinfiltration, enhanced by host pathway manipulation and self-replicating single-stranded DNA viral vectors

This multi-platform approach lets partners select the expression strategy best suited to their protein class, yield requirements, and development timeline.

Technical specifications

Membrane protein platform

  • Engineered photosynthetic bacteria (Rhodobacter) with light-harvesting proteins replaced by target membrane proteins
  • Ultra-high-density thin-film anaerobic bioreactor improves yields by orders of magnitude over conventional culture
  • Functional recovery demonstrated by reconstituting expressed aquaporins into vesicles
  • Scalability validated through pilot-scale trickle-bed bioreactors; relevant bioreactor IP is patented and active

Direct mRNA delivery platform

  • Delivers mRNA directly into plant protoplasts (plant cells with cell walls removed), bypassing transcriptional constraints
  • Enables rapid microgram-scale screening of multiple protein variants
  • Optimization includes codon usage strategies to reduce mRNA turnover

Transient agroinfiltration platform

  • Agrobacterium-mediated transient expression in plant tissues
  • Boosts production by co-suppressing gene silencing and manipulating the plant TOR growth-regulating pathway
  • Systemic, self-replicating ssDNA viral vectors support scale-up
Technology readiness level

The membrane protein platform has reached pilot scale, with patented bioreactor technology, orders-of-magnitude yield improvement, and functional protein recovery demonstrated. The direct mRNA delivery system is in active optimization for rapid small-scale screening. The agroinfiltration and viral-vector platform has been refined over many years; near-term steps include updating regulatory permits for viral vectors and establishing comparative expression data across plant tissues. Future validation plans include selecting 3–5 protein targets with existing functional assays, establishing microgram-level purification from simple culture, and evaluating scale-up for the most promising candidates. The platform portfolio is available for collaborative development, sponsored research, licensing, and pilot trial engagement.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.